Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2001
10/04/2001EP1137797A1 Expression system for factor viii
10/04/2001EP1137796A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/04/2001EP1137793A2 Novel nucleic acid transferring agents, compositions containing them and uses
10/04/2001EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
10/04/2001EP1137785A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE
10/04/2001EP1137783A2 Beta-1,3-galactosyltransferase homologs
10/04/2001EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
10/04/2001EP1137775A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN
10/04/2001EP1137774A2 Grnf4, a gdnf-related neurotrophic factor
10/04/2001EP1137773A2 Growth factor homolog zvegf3
10/04/2001EP1137772A1 Spermatogenesis protein
10/04/2001EP1137770A2 Heat shock genes and proteins from neisseria meningitidis, candida glabrata and aspergillus fumigatus
10/04/2001EP1137764A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
10/04/2001EP1137762A1 Treatment of pompe's disease
10/04/2001EP1137667A2 Analogues of glp-1
10/04/2001EP1137666A1 Glp-1 analogues
10/04/2001EP1137665A1 Cark protein and nucleic acid molecules and uses therefor
10/04/2001EP1137664A2 Protein transduction system and methods of use thereof
10/04/2001EP1137663A2 Purification of echinocandin cyclopeptide compounds
10/04/2001EP1137662A1 Pharmaceutical compositions comprising quinapril magnesium
10/04/2001EP1137661A1 Procollagen c-proteinase inhibitors
10/04/2001EP1137659A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
10/04/2001EP1137658A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR $g(a)-INDUCED EXPRESSION OF CELL ADHESION MOLECULES
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
10/04/2001EP1137465A1 Method for purification of a blood component
10/04/2001EP1137446A1 Collagen hemostatic foam
10/04/2001EP1137436A1 Stimulation of t cells against self antigens using ctla-4 blocking agents
10/04/2001EP1137433A2 Pharmaceutical compositions containing protein-disulfide isomerases
10/04/2001EP1137432A1 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome
10/04/2001EP1137431A1 Pharmaceutical compositions containing insulin
10/04/2001EP1137430A2 Therapeutic agent for the suppression of snoring noises
10/04/2001EP1137427A1 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
10/04/2001EP1137426A1 Cancer treatment composition and method using natural plant essential oils
10/04/2001EP1137425A1 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils
10/04/2001EP1137422A2 Use of human prostate cell lines in cancer treatment
10/04/2001EP1137419A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
10/04/2001EP1137402A1 Phospholipid compositions
10/04/2001EP1137401A1 Administration of neurotrophic agents to the central nervous system
10/04/2001EP1137400A1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period toff, verfahren zu seiner herstellung und anlage zur durchfuhrung des verfahrens
10/04/2001EP1137340A1 Composition and method for regulation of body weight and associated conditions
10/04/2001EP1079852B1 Composition based on pentoxifylline and anticytokin
10/04/2001EP0981282A4 Process for preparing a nutritional supplement
10/04/2001EP0853614B1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
10/04/2001EP0815123B1 Beta-sheet mimetics and use thereof as protease inhibitors
10/04/2001EP0802909B1 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/04/2001EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
10/04/2001EP0682524B1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
10/04/2001EP0674646B1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/2001EP0668876B1 Treatment of infertility and enhancement of fertilization capacity in mammalian males by thymosin peptide and its antibodies
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001EP0606463B1 Neuromedin b receptor antagonists
10/04/2001DE10048710A1 Composition for treating or preventing tumors, comprises plasmids, and optionally recombinant viruses, that express mucin and carcino-embryonal antigen
10/04/2001DE10018335A1 New spatial model of polypeptide containing a TPR motif, useful for identifying inhibitors of interaction between chaperone and Hop proteins, potential therapeutics
10/04/2001CA2659030A1 Methods for inhibiting angiogenesis and tumor growth
10/04/2001CA2429196A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/04/2001CA2407045A1 Apoptin-associating protein
10/04/2001CA2405502A1 Method of treating hepatitis delta viral infection
10/04/2001CA2404964A1 Methods for detecting inflammation and inflammatory conditions
10/04/2001CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
10/04/2001CA2404660A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter
10/04/2001CA2404658A1 3d structure of polypeptides containing a tpr-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said peptides
10/04/2001CA2404574A1 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2404570A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/04/2001CA2404532A1 Method of identifying inhibitors of tie-2
10/04/2001CA2404528A1 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
10/04/2001CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001CA2404461A1 Human g-protein coupled receptors
10/04/2001CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001CA2404432A1 Compositions and methods for identifying and targeting cancer cells
10/04/2001CA2404428A1 High specificity marker detection
10/04/2001CA2404390A1 Methods of therapy for non-hodgkin's lymphoma using a combination of an antibody to cd20 and interleukin-2
10/04/2001CA2404374A1 Use of metal salts to stabilize taxane-based compositions
10/04/2001CA2404370A1 Taxane-based compositions and methods of use
10/04/2001CA2404310A1 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
10/04/2001CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer
10/04/2001CA2404231A1 Methods of treating diseases with activated protein c
10/04/2001CA2404202A1 Compounds and methods for modulating desmosomal cadherin-mediated functions
10/04/2001CA2404100A1 Therapeutic peptides having a motif that binds specifically to non-acetylated h3 and h4 histones for cancer therapy
10/04/2001CA2404077A1 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies
10/04/2001CA2404060A1 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
10/04/2001CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001CA2403764A1 Methods for immunostimulation using binding agents for the fc receptor of immunoglobulin a
10/04/2001CA2403637A1 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
10/04/2001CA2403555A1 Methods for effecting neuroprotection
10/04/2001CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001CA2402780A1 Insulin and igf-1 receptor agonists and antagonists
10/04/2001CA2402769A1 Ceramide derivatives and method of use
10/04/2001CA2402735A1 Human transcription factors
10/04/2001CA2402453A1 Compounds for targeting
10/04/2001CA2402439A1 Methods of modulating drug clearance mechanisms by altering sxr activity
10/04/2001CA2401638A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/04/2001CA2401120A1 Lactams as inhibitors of a-beta protein production
10/04/2001CA2400573A1 Alteration of cellular behavior by antisense modulation of mrna processing
10/04/2001CA2374911A1 G-protein coupled receptors
10/03/2001CN1315998A Compositions and methods for therapy and diagnosis of prostate cancer
10/03/2001CN1315965A Hepatitis C inhibitor peptides
1 ... 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 ... 3163